February 3, 2014
Media Advisory: UCLA Fielding School of Public Health Study prompts FDA investigation
The U.S. Food and Drug Administration (FDA) is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products following an FSPH study.